Your browser doesn't support javascript.
loading
BLT2, a leukotriene B4 receptor 2, as a novel prognostic biomarker of triple-negative breast cancer.
Park, JaeIn; Jang, Jae-Hyun; Park, Geun-Soo; Chung, Yunro; You, Hye Jin; Kim, Jae-Hong.
Affiliation
  • Park J; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
  • Jang JH; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
  • Park GS; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
  • Chung Y; Department of Biomedical Informatics, Arizona State University, Scottsdale, AZ 85259, USA.
  • You HJ; Translational Research Branch, Division of Translational Science, National Cancer Center, Goyang 10408, Korea.
  • Kim JH; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
BMB Rep ; 51(8): 373-377, 2018 Aug.
Article in En | MEDLINE | ID: mdl-29898809
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Leukotriene B4 / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: BMB Rep Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Leukotriene B4 / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: BMB Rep Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA Year: 2018 Document type: Article Country of publication: